These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38956676)

  • 41. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
    Lemyre B; Deguise MO; Benson P; Kirpalani H; Ekhaguere OA; Davis PG
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005384. PubMed ID: 37466143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial.
    Zhou R; Xiong T; Tang J; Huang Y; Liu W; Zhu J; Chen C; Gong L; Tian K; Wang A; Mu D
    Trials; 2023 Oct; 24(1):647. PubMed ID: 37803402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
    Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
    JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol.
    Zhang H; Li J; Zeng L; Gao Y; Zhao W; Han T; Tong X
    Front Pediatr; 2022; 10():968462. PubMed ID: 35967549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
    Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
    Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
    PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
    Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
    J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
    Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
    Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
    Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
    Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.